This is a ready-to-use protocol for the product-specific validation of a 0.2 micron sterilizing-grade filter. It is separate from and in addition to the filter manufacturer’s generic qualification, which uses a surrogate fluid and cannot stand in for a study on your own product and process. Replace every <<FILL: ...>> placeholder with your specifics, set your document numbers and dates, and route it through your normal document control, review, and approval. A worked filled specimen follows the template. This content is educational and general; adapt and verify it for your product, filter, and regulatory commitments, and confirm every cited reference against the current published source before you rely on it.
Approval page
| Field | Entry |
|---|---|
| Document title | Sterilizing-Grade Filter Validation, <<FILL: product / process name>> |
| Document number | <<FILL: PROT-ID, e.g. VAL-FLT-001>> |
| Version | <<FILL: version>> |
| Effective date | <<FILL: effective date>> |
| Filter under study | <<FILL: manufacturer, model, membrane chemistry, pore rating>> |
| Product / process | <<FILL: product name, strength, batch scale>> |
| Supersedes | <<FILL: prior version or "New">> |
| Approval | Name | Signature | Date |
|---|---|---|---|
| Author (Validation) | <<FILL>> | ||
| Filtration / Process SME | <<FILL>> | ||
| Microbiology | <<FILL>> | ||
| Quality Assurance | <<FILL>> |
1. Objective
Demonstrate, on the actual product (or a justified surrogate matched for the properties that affect filter performance), that the named filter produces sterile effluent when challenged with the required bacterial load under worst-case process conditions, that a non-destructive integrity test result correlates to that retention for the wetting fluid actually used, and that the filter is chemically compatible with the product, does not remove product components by adsorption beyond an acceptable level, and does not contribute extractables or leachables above a toxicologically justified limit. The output is a set of production integrity-test limits and process parameters that the routine filtration step is validated to operate within.
2. Scope
This protocol covers the product-specific (process-specific) validation of the named sterilizing-grade filter for <<FILL: product / process>>, including bacterial retention, integrity test correlation, chemical compatibility, adsorption, and extractables/leachables. It does not cover the filter manufacturer’s generic qualification, which is accepted as prerequisite input (section 4), nor the sizing study, which is addressed by <<FILL: sizing worksheet ID>>, nor the PUPSIT decision, which is addressed by <<FILL: PUPSIT risk assessment ID>>. Routine production use of the validated filter is governed by <<FILL: production filtration SOP ID>>.
3. System and process description
| Item | Detail |
|---|---|
| Filter make, model, membrane chemistry | <<FILL: e.g. PES 0.2 micron, 10-inch cartridge>> |
| Filtration step in the process | <<FILL: final sterilizing filtration before fill; or bulk filtration>> |
| Product | <<FILL: name, strength, formulation summary>> |
| Batch scale and filter configuration | <<FILL: batch volume, single or redundant filter, area>> |
| Process parameters under study | <<FILL: pressure, flow, temperature, contact time, throughput>> |
| Filter sterilization method | <<FILL: autoclave / steam-in-place, cycle reference>> |
4. Prerequisites
- Filter manufacturer’s generic validation guide available, including generic bacterial retention data, generic extractables profile, and the vendor’s water-wet integrity test limits for the filter type.
- Filter sizing study complete and approved (
<<FILL: worksheet ID>>). - Filtration process parameters (pressure, time, temperature, throughput) defined from process development or engineering runs.
- Integrity test instrument qualified, with a validated recipe and audit trail enabled (
<<FILL: instrument qualification reference>>). - Test laboratory (internal or contract) qualified to perform ASTM F838 bacterial challenge testing, with a current viability-control procedure.
5. Responsibilities
| Role | Responsibility |
|---|---|
| Validation / Filtration SME | Designs and executes (or oversees the contract laboratory executing) the studies, sets worst-case conditions, drafts the protocol and report |
| Manufacturing / Process owner | Provides representative product/bulk for testing, confirms process parameters are correctly represented, supports execution |
| Microbiology | Performs or oversees the bacterial challenge testing and viability controls, reviews the challenge organism preparation and effluent culture method |
| Quality Assurance | Approves the protocol and report, the acceptance criteria, and the locked integrity limits; dispositions deviations |
6. Worst-case conditions and bracketing basis
State the basis for each worst-case parameter bracketed in this study. The study must use conditions at least as severe as anything the routine process will see.
| Parameter | Worst-case value used in study | Basis |
|---|---|---|
| Maximum product contact time (including hold) | <<FILL>> | <<FILL: validated hold time / campaign reuse claim>> |
| Maximum differential pressure / flux | <<FILL>> | <<FILL: process range upper limit>> |
| Temperature | <<FILL>> | <<FILL: process range upper limit>> |
| Total throughput per filter | <<FILL>> | <<FILL: maximum batch volume per filter, including reuse>> |
| Pre-use sterilization applied to test filter | <<FILL: cycle used>> | Matches production filter history |
| Test fluid | <<FILL: actual product, product-then-challenge, or justified surrogate>> | <<FILL: bactericidal/bacteriostatic assessment; surrogate match rationale if used>> |
7. Test cases
| TC ID | Test | Steps | Expected result | Actual | Pass/Fail | Tester / Date |
|---|---|---|---|---|---|---|
| TC-01 | Viability control | Suspend challenge organism in the test fluid for the maximum test duration; plate and count at start and end | Organism count confirms survival throughout the test window | |||
| TC-02 | Bacterial retention challenge, filter lot 1 | Filter product under worst-case conditions, then challenge with B. diminuta at >= 1 x 10^7 CFU/cm^2; culture the downstream effluent | No growth in effluent; positive control grows | |||
| TC-03 | Bacterial retention challenge, filter lot 2 | Repeat TC-02 on a second manufacturing lot | No growth in effluent; positive control grows | |||
| TC-04 | Bacterial retention challenge, filter lot 3 | Repeat TC-02 on a third manufacturing lot | No growth in effluent; positive control grows | |||
| TC-05 | Integrity test correlation | Record bubble point / diffusive flow / pressure hold on each challenged filter before and after the bacterial challenge | Integrity values before and after correlate with retention; production limit derivable with margin | |||
| TC-06 | Product-wetted vs water-wetted limit | Compare integrity value with filter wetted by product against the water-wet vendor limit | Product-wetted limit established or a validated flush-to-water-wet procedure confirmed | |||
| TC-07 | Chemical compatibility | Expose filter to product (or representative matrix) for the maximum cumulative contact time at maximum temperature; examine membrane, housing, and O-rings; retest integrity | No degradation of mechanical integrity or integrity test value; no unexpected change to the fluid | |||
| TC-08 | Adsorption | Measure active and/or preservative concentration upstream and in the filtrate across the run, including first and last portions | Filtrate concentration within release specification throughout | |||
| TC-09 | Extractables and leachables | Review vendor extractables data against product contact time, surface-area-to-volume ratio, and route of administration; perform confirmatory leachables testing if warranted by the risk assessment | Identified compounds within toxicologically justified limits; flush claim (if any) validated |
8. Acceptance criteria
The filter is considered validated for this product and process when all of the following hold:
- Viability control confirms the challenge organism survives the full test duration in the test fluid used.
- All bacterially challenged filters (a minimum of three manufacturing lots) show sterile effluent, no growth, at a challenge of at least 1 x 10^7 CFU per cm^2 of effective filtration area.
- The integrity test values of the challenged filters correlate to retention, and a production integrity-test limit (bubble point minimum, diffusive flow maximum, or pressure hold maximum, as applicable) is derived with a documented margin below the lowest value at which retention was demonstrated.
- The production integrity-test limit is specific to the wetting fluid actually used in routine testing (product-wetted, or a validated flush-to-water-wet limit).
- The filter shows no loss of mechanical integrity and no adverse change in integrity test value after exposure to the maximum cumulative product contact time and temperature.
- Filtrate concentration of the active and, where applicable, an antimicrobial preservative remains within release specification across the batch, including the first and last portions filtered.
- Identified extractables or leachables are within a documented toxicologically justified limit, and any pre-use flush claimed is specified and validated.
9. Deviation handling
Record any departure from this protocol, including an unexpected integrity test result, growth in a viability or positive control, or a process parameter outside the study’s stated range, on a deviation record per <<FILL: deviation SOP ID>>. Assess the impact on the validation conclusion before proceeding, and obtain Quality Assurance disposition. A challenged filter that fails retention is not retested into a pass; it is investigated, and the investigation outcome (test-system cause versus genuine filter failure) is documented before the study conclusion is finalized.
10. Summary and conclusion
Summarize the bacterial retention results by lot, the viability control outcome, the derived integrity-test correlation and production limit (stated per wetting fluid), the chemical compatibility outcome, the adsorption result against the release specification, and the extractables/leachables conclusion. State the validated process envelope (the worst-case parameters this validation supports) and the resulting production integrity-test method and limit that are to be transcribed into the routine filtration SOP and the integrity test instrument recipe. Route the report through the approval page roles.
11. References
ASTM F838, Standard Test Method for Determining Bacterial Retention of Membrane Filters Utilized for Liquid Filtration (current revision F838-20 at time of writing). EU GMP Annex 1, Manufacture of Sterile Medicinal Products (2022), section 8, filtration and integrity testing. FDA Guidance for Industry, Sterile Drug Products Produced by Aseptic Processing, Current Good Manufacturing Practice (2004). PDA Technical Report No. 80, Application of Pre-Use Post-Sterilization Integrity Testing (PUPSIT) (referenced where the PUPSIT decision interacts with this validation). 21 CFR 211.72 and 211.113 (filters and filtration; control of microbiological contamination). ICH Q9, Quality Risk Management (worst-case and risk-based study design).
Confirm the current version and clause numbers of each reference before issue. ASTM, PDA, and similar technical documents are copyrighted; cite by number and title and describe them in your own words rather than pasting their text.
12. Revision history
| Version | Date | Author | Summary of change |
|---|---|---|---|
<<FILL: 1.0>> | <<FILL: date>> | <<FILL: author>> | Initial issue. |
Filled specimen
The following shows TC-02 through TC-06 completed for an example 0.2 micron PES filter validated for a 200 L monoclonal antibody drug product batch. Numbers are illustrative; replace them with your own.
Test fluid decision: the product contains polysorbate 80 and does not reliably support B. diminuta survival over the test window, so product-then-challenge was used: the actual bulk was filtered first at worst-case conditions, then the wetted filter was immediately challenged with organisms suspended in a viability-supporting fluid.
| TC ID | Result |
|---|---|
| TC-01 | Viability control: organism count stable across the 4-hour test window, confirming a valid challenge |
| TC-02, TC-03, TC-04 | Three filter lots challenged at 1.4 to 1.8 x 10^7 CFU/cm^2 after 2.0 bar, 6-hour worst-case product contact; no growth in any downstream effluent; positive controls grew |
| TC-05 | Diffusive flow recorded on all three challenged filters, 8 to 13 mL/min; no failing filters in this batch of correlation data, so the production limit was set from the vendor’s broader correlation set at 15 mL/min with margin, consistent with these results |
| TC-06 | Water-wet vendor limit did not apply directly because of the polysorbate; a controlled water flush to a defined endpoint was validated, and the water-wet limit was confirmed usable after that flush |
Conclusion: the filter is validated for this product at the studied worst-case conditions, with a production diffusive flow maximum of 15 mL/min applied after the validated water flush.
Common inspection findings this protocol prevents
- Relying on the filter vendor’s generic broth-based bacterial retention data with no product-specific challenge.
- No viability control, so retention is claimed on organisms that may have been dying in the test fluid.
- An integrity-test limit taken from the vendor’s water-wet specification and applied to a product-wetted filter with no correlation or validated flush.
- Only one filter lot challenged, missing manufacturing-lot variability.
- No chemical compatibility data at the actual maximum contact time and temperature.
- Adsorption not assessed for a low-concentration active or preservative.
- Extractables and leachables not evaluated for the actual product and route of administration.
How to adapt this protocol
- Set your document number, filter, and product in the approval page and section 3.
- Complete the worst-case bracketing table (section 6) from your actual process range before designing the study.
- Decide the test fluid strategy (actual product, product-then-challenge, or surrogate) and document the rationale; involve microbiology early if the product is bactericidal or bacteriostatic.
- Size each test case to the number of filter lots and replicates your risk assessment and statistical basis require.
- Confirm every reference in section 11 against the current published version before issue.